Krishna Institute of Medical Sciences (KIMS) has reported a profit of ₹588 million for the second quarter of fiscal year 2025, as announced in a board meeting held on November 7, 2025. This profit reflects an increase compared to the previous quarter, where the profit stood at ₹797 million. The company's total income for the quarter reached ₹4,300 million, which is an improvement over the ₹3,734 million reported in the first quarter. The financial results, which include both standalone and consolidated figures, were reviewed by the Audit Committee prior to the board's approval.

In addition to financial performance, KIMS has also approved a merger of two wholly-owned subsidiaries, KIMS Hospitals Private Limited and Chalasani Hospitals Private Limited, into the holding company, Krishna Institute of Medical Sciences Limited. This strategic move aims to streamline operations and enhance efficiency within the organization. The financial results for KIMS can be accessed on their official website as well as on the BSE and NSE platforms, in compliance with SEBI regulations.

The report also highlighted the company's expenses, which totaled ₹3,501 million for the quarter, representing an increase from ₹2,708 million in the previous quarter. Major contributors to these expenses included employee benefits and other operational costs. The earnings per share for KIMS stood at ₹159 for the quarter, consistent with the company’s focus on maintaining robust financial health while expanding its healthcare services. Overall, KIMS appears to be in a solid position, demonstrating growth in income and strategic expansion through its mergers.